Biomarkers and Biosimilars in Diabetes

Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product.  Human bio monitoring (HBM) is a tool of health-related environmental monitoring.

Diabetes is a major lifestyle disease, It is necessary to identify potential biomarkers associated with diabetes for early detection and proper management of diabetes.  Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Hemoglobin A1c is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Related Conference of Biomarkers and Biosimilars in Diabetes

October 16-17, 2023

4th Asia Pacific Congress on Diabetes and Endocrinology

Vancouver, Canada
October 16-17, 2023

2nd World congress and Expo on Diabetes

Vancouver, Canada
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA
November 13-14, 2023

3rd European Endocrinology and Diabetes Congress

Paris, France
November 16-17, 2023

7th Annual Conference on Diabetes and Endocrinology

Paris, France
November 20-21, 2023

17th European Diabetes and Endocrinology Congress

Dubai, UAE
November 22-23, 2023

19th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2023

27th International Conference on Diabetes, Endocrinology and Healthcare

Singapore City, Singapore
January 11-12, 2024

5th Global summit on Diabetes and Endocrinology

Dubai, UAE
February 08-09, 2024

33rd European Diabetes Congress

Paris, France
March 25-26, 2024

5th Annual Conference on Diabetes

London, UK

Biomarkers and Biosimilars in Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in